BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 23647606)

  • 21. Activation of calcium/calmodulin-dependent protein kinase IIalpha in the striatum by the heteromeric D1-D2 dopamine receptor complex.
    Ng J; Rashid AJ; So CH; O'Dowd BF; George SR
    Neuroscience; 2010 Jan; 165(2):535-41. PubMed ID: 19837142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T; Seeman P; Kuroiwa M; Nishi A
    Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histamine H3 receptor activation inhibits dopamine D1 receptor-induced cAMP accumulation in rat striatal slices.
    Sánchez-Lemus E; Arias-Montaño JA
    Neurosci Lett; 2004 Jul; 364(3):179-84. PubMed ID: 15196671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alcohol intake enhances glutamatergic transmission from D2 receptor-expressing afferents onto D1 receptor-expressing medium spiny neurons in the dorsomedial striatum.
    Lu J; Cheng Y; Wang X; Woodson K; Kemper C; Disney E; Wang J
    Neuropsychopharmacology; 2019 May; 44(6):1123-1131. PubMed ID: 30733568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting VGLUT2 in Mature Dopamine Neurons Decreases Mesoaccumbal Glutamatergic Transmission and Identifies a Role for Glutamate Co-release in Synaptic Plasticity by Increasing Baseline AMPA/NMDA Ratio.
    Papathanou M; Creed M; Dorst MC; Bimpisidis Z; Dumas S; Pettersson H; Bellone C; Silberberg G; Lüscher C; Wallén-Mackenzie Å
    Front Neural Circuits; 2018; 12():64. PubMed ID: 30210305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism.
    Abercrombie ED; DeBoer P
    J Neurosci; 1997 Nov; 17(21):8498-505. PubMed ID: 9334422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.
    Edwards S; Whisler KN; Fuller DC; Orsulak PJ; Self DW
    Neuropsychopharmacology; 2007 Feb; 32(2):354-66. PubMed ID: 16541082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.
    Aubert I; Ghorayeb I; Normand E; Bloch B
    J Comp Neurol; 2000 Feb; 418(1):22-32. PubMed ID: 10701753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids.
    André VM; Cepeda C; Cummings DM; Jocoy EL; Fisher YE; William Yang X; Levine MS
    Eur J Neurosci; 2010 Jan; 31(1):14-28. PubMed ID: 20092552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histamine H3 receptor activation inhibits dopamine synthesis but not release or uptake in rat nucleus accumbens.
    Aquino-Miranda G; Escamilla-Sánchez J; González-Pantoja R; Bueno-Nava A; Arias-Montaño JA
    Neuropharmacology; 2016 Jul; 106():91-101. PubMed ID: 26169221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors.
    Wang JQ; McGinty JF
    J Pharmacol Exp Ther; 1997 May; 281(2):972-82. PubMed ID: 9152408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction.
    Martinez D; Saccone PA; Liu F; Slifstein M; Orlowska D; Grassetti A; Cook S; Broft A; Van Heertum R; Comer SD
    Biol Psychiatry; 2012 Feb; 71(3):192-8. PubMed ID: 22015315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity.
    Trifilieff P; Martinez D
    Neuropharmacology; 2014 Jan; 76 Pt B(0 0):498-509. PubMed ID: 23851257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane properties of striatal direct and indirect pathway neurons in mouse and rat slices and their modulation by dopamine.
    Planert H; Berger TK; Silberberg G
    PLoS One; 2013; 8(3):e57054. PubMed ID: 23469183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opposite influences of endogenous dopamine D1 and D2 receptor activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis.
    West AR; Grace AA
    J Neurosci; 2002 Jan; 22(1):294-304. PubMed ID: 11756513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha1b-adrenergic receptors control locomotor and rewarding effects of psychostimulants and opiates.
    Drouin C; Darracq L; Trovero F; Blanc G; Glowinski J; Cotecchia S; Tassin JP
    J Neurosci; 2002 Apr; 22(7):2873-84. PubMed ID: 11923452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors.
    Hawes SL; Salinas AG; Lovinger DM; Blackwell KT
    J Physiol; 2017 Aug; 595(16):5637-5652. PubMed ID: 28449351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural substrates of drug craving and relapse in drug addiction.
    Self DW
    Ann Med; 1998 Aug; 30(4):379-89. PubMed ID: 9783837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histamine H3 and dopamine D2 receptor-mediated [35S]GTPgamma[S] binding in rat striatum: evidence for additive effects but lack of interactions.
    Humbert-Claude M; Morisset S; Gbahou F; Arrang JM
    Biochem Pharmacol; 2007 Apr; 73(8):1172-81. PubMed ID: 17306767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice.
    Gomez-Sintes R; Bortolozzi A; Artigas F; Lucas JJ
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1524-33. PubMed ID: 25088904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.